10.77021.21% ( -2.900 )
Closed: Nov 16, 16:00:00 (EDT)Overview
TRex Bio (TRXB)
TRex Bio, Inc. develops immunoregulatory biologics for autoimmune and inflammatory diseases in United States and Internationally. The company operates the Deep...
- Open
- 13.940
- High
- 13.940
- Low
- 10.760
- Prev. Close
- 13.670
- Volume
- 123.20K
- Turnover
- 1.52M
- Avg Price
- 12.328
- Bid/Ask Ratio
- -100.00%
- Amplitude
- 23.26%
- 52wk High
- 16.561
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.92%
- 52wk Low
- 10.760
- Float Mkt Cap
- 144.60M
- Market CapUSD
- 289.95M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.72
- EPSDynamic
- -2.18
- EPSStatic
- --
- BVPS
- -4.50
- P/B
- --
- Circulating Supply
- 13.43M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 26.92M
- Min lot size
- 1
- Currency
- USD
TRex Bio Analyst Rating
View moreForecast & Rating
Nov 3, 2026Price forecast
$29.25162.10%
Forecast & RatingStrong buy
5analysts
- Strong buy80.00%
- Buy20.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 4
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
Market Movers · TRex Bio tumbles 16% as Q3 EPS declines year-over-year
benzinga_article · TRex Bio shares are trading lower after the company reported a year-over-year decrease in its Q3 EPS results.
Market Movers · TRex Bio surges 10%
Market Movers · TRex Bio surges 8%
Market Movers · TRex Bio falls 5% to hit 52-week low
benzinga_article · This X-Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
